EUVIMEDEUVIMED entdecken
Crossref

Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study

Feifei Lu, Qing Wu, Jiaming Lei, Yanhong Zhou, Yifei Liu, Ni Zhu, You Yu, Li Lin, Meichun Hu

Archives of Biochemistry and Biophysics · 2024

DOI: 10.1016/j.abb.2024.109957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Feifei Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China; Key Laboratory of Environmental…. Hauptthemen laut MEDLINE: Glioblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Health and Family Planning Commission of Hubei Province, Hubei Provincial Department of Education, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate the therapeutic effects of Zeaxanthin (Zea), one of the oxidized xanthophyll carotenoids belonging to the isoprenoids, on inhibiting the angiogenesis and tumor growth of glioblastoma (GBM) via an in vitro and in vivo study. METHODS: The effects of Zea on the proliferation, adhesion, migration and invasion of human GBM cell lines were detected by cell proliferation assay, cell adhesion assay and Transwell assay. The effect of Zea on angiogenesis was detected by rat aortic ring assay and human umbilical vein endothelial cells (HUVEC) in vitro tube formation assay. The effects of Zea on PARP, Caspase 3 and VEGFR2 phosphorylation as well as VEGFR2's downstream signaling pathway were detected by Western blot. The in vivo human GBM xenograft mouse model was employed to study the therapeutic efficacy of Zea. RESULTS: Zea impaired the proliferation, adhesion, migration and invasion of U87 and U251 cells as well as HUVECs. Rat aortic ring experiments displayed Zea significantly inhibited angiogenesis during VEGF-induced microvascular germination. In vitro and in vivo vascular experiments verified that Zea inhibited VEGF-induced HUVEC proliferation and capillary-like tube formation. Additionally, Zea induced GBM cells apoptosis via increasing the expression of cleaved PARP and Caspase 3. In HUVECs and U251 GBM cells, Zea down-regulated VEGF-induced activation of the VEGFR2 kinase pathway. Meanwhile the expression of p-AKT, p-ERK, p-STAT3 and FAK were all attenuated in U251 cells. Moreover, the effects of Zea on GBM cells proliferation could be blocked by VEGFR2 kinase inhibitor SU5408. These results suggest that Zea may hinder GBM angiogenesis and tumor growth through down-regulating a cascade of oncogenic signaling pathways, both through the inhibition of angiogenesis and the anti-tumor mechanism of a direct cytotoxic effect. Besides, Zea inhibits GBM angiogenesis and tumor growth exemplified through a xenograft mouse model in vivo. CONCLUSION: Zea impairs angiogenesis and tumor growth of GBM both in vitro and in vivo. It can be declared that Zea is a potential valuable anticancer candidate for the future treatment strategy of GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaAntineoplastic AgentsHumansRatsMiceAnimalsZeaxanthinsCaspase 3Vascular Endothelial Growth Factor AAngiogenesisPoly(ADP-ribose) Polymerase InhibitorsAngiogenesis InhibitorsCell ProliferationHuman Umbilical Vein Endothelial CellsNeovascularization, PathologicCell Movement

Stichwörter der Autor:innen

AngiogenesisGlioblastomaTumor growthVascular endothelial growth factor receptor 2Zeaxanthin

Substanzen

ZeaxanthinsCaspase 3Vascular Endothelial Growth Factor APoly(ADP-ribose) Polymerase InhibitorsAngiogenesis InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China; Key Laboratory of Environmental Related Diseases and One Health, School of Basic Medical Sciences, Xi…
  • Department of Medical School of Facial Features, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China.
  • School of Biomedical Engineering, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China.
  • Key Laboratory of Environmental Related Diseases and One Health, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China.
  • Key Laboratory of Environmental Related Diseases and One Health, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China. Electronic address: al…
  • Key Laboratory of Environmental Related Diseases and One Health, School of Basic Medical Sciences, Xianning Medical College, Hubei University of Science and Technology, Xianning, 437100, PR China. Electronic address: hu…

Förderung

  • Health and Family Planning Commission of Hubei Province
  • Hubei Provincial Department of Education
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Hubei University of Science and Technology

Zitieren

APA

Lu, F., Wu, Q., Lei, J., Zhou, Y., Liu, Y., Zhu, N., Yu, Y., Lin, L., & Hu, M. (2024). Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.109957

Vancouver

Lu F, Wu Q, Lei J, Zhou Y, Liu Y, Zhu N, et al. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.109957

BibTeX
@article{Lu2024,
  author = {Lu, Feifei and Wu, Qing and Lei, Jiaming and Zhou, Yanhong and Liu, Yifei and Zhu, Ni and Yu, You and Lin, Li and Hu, Meichun},
  title = {Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1016/j.abb.2024.109957}
}
Kostenlos starten →